Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation.
Authors: Hardy NM,  Grady C,  Pentz R,  Stetler-Stevenson M,  Raffeld M,  Fontaine LS,  Babb R,  Bishop MR,  Caporaso N,  Marti GE
Journal: Br J Haematol
Date: 2007 Dec
Branches: GEB
PubMed ID: 18021093
PMC ID: not available
Abstract: Monoclonal B-cell lymphocytosis (MBL) is a recently described laboratory finding in otherwise healthy individuals. In MBL, a light chain-restricted, clonal B-cell population, often with a chronic lymphocytic leukaemia (CLL) phenotype, is identified by flow cytometry. Although the prognostic significance remains unclear, there is an increased incidence in ageing populations and those with a family history of CLL. During the past decade of MBL study, three families have come to our attention in which prospective sibling haematopoietic stem cell donors were found to have an MBL. These families raise complex bioethical issues with regard to disclosure of research data, eligibility for clinical trials and potential donor transfer of MBL. These issues are explored in this report. Identification of MBL among prospective sibling transplant donors will become a common occurrence in transplant practice as transplantation is increasingly offered to older individuals and those with CLL.